UK MHRA approves MSD’s pulmonary arterial hypertension therapy
MSD has received the UK MHRA approval for sotatercept, marketed as Winrevair, to treat PAH in the adult population.
MSD has received the UK MHRA approval for sotatercept, marketed as Winrevair, to treat PAH in the adult population.
What's Your Reaction?
